UHS

Universal Health ServicesNYSE · Health Care Facilities · Health Care

Previous close

181.21

Change

+4.36 / +2.47%

FinDog View

Neutral

52-Week Range

140.08 – 246.33

P/E (TTM)

7.0

Forward P/E

6.9

Based on consensus earnings for the next 12 months

Market Cap

$10.7B

+6.26%

S&P 500 −2.41% over same period

Volume / Avg Volume

882K / 690K

1.28× average

Price History

Closing price · USD1M 6M 1Y 5Y

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 7.01M 6M 1Y 5Y

Recent Earnings

Click to read the FinDog analysis

Period	Reported	Revenue	EPS Actual / Est.	Next-Day Move	Analysis
FY2026 Q2 Quarter ended 2026-06	2026-07-28	$4.6B	5.98 / 6.02	+1.17%	Pending
FY2026 Q1 Quarter ended 2026-03	2026-04-28	$4.5B	5.62 / 5.46	+3.34%	Pending
FY2025 Q4 Quarter ended 2025-12	2026-02-25	—	— / —	−11.44%	Pending
FY2025 Q3 Quarter ended 2025-09	2025-10-28	—	— / —	+2.73%	Pending
FY2025 Q2 Quarter ended 2025-06	2025-07-29	—	— / —	+1.61%	Pending
FY2025 Q1 Quarter ended 2025-03	2025-04-29	—	— / —	+3.02%	Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data

Valuation

P/E is at percentile 7 of its 5-year rangeCheap

5-year range 6.5 – 17.3 · Median 11.6

Last 4 quarters: $1.1B in buybacks + $49.6M in dividends, 10.52% of market cap combined

P/E (TTM)

7.0

P/B

1.4

P/S

0.6

Dividend Yield

0.58%

Earnings Reaction

Over the last 6 reports, the stock moved ±3.9% on average on the first trading day after, rising 5 times

Most recent +1.17%

Volatility & Correlation

1-year beta 0.08 · Correlation with S&P 500 0.03Low beta

Annualized volatility 32% vs. 14% for the S&P 500

Insider Trading

View all →

Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions

No open-market buys or sells by officers or directors in the last 90 days.

Multi-Quarter Financial Trends

View all quarters →

Last 12 quarters · As reported by the company

Quarter	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Free Cash Flow ($B)	EPS
FY2026 Q2	4.64	+8.3%	—	0.52	0.36	0.22	5.98
FY2026 Q1	4.50	+9.6%	—	0.50	0.35	0.18	5.65
FY2025 Q4	4.49	+9.1%	—	0.52	0.45	0.29	7.01
FY2025 Q3	4.50	+13.4%	—	0.52	0.37	0.15	5.86
FY2025 Q2	4.28	+9.6%	—	0.50	0.35	0.28	5.43
FY2025 Q1	4.10	+6.7%	—	0.45	0.32	0.12	4.80
FY2024 Q4	4.11	+11.1%	—	0.47	0.33	0.41	4.94
FY2024 Q3	3.96	+11.2%	—	0.38	0.26	0.09	3.80
FY2024 Q2	3.91	+10.1%	—	0.44	0.29	0.44	4.26
FY2024 Q1	3.84	+10.8%	—	0.39	0.26	0.19	3.82
FY2023 Q4	3.70	+7.4%	—	0.33	0.22	0.25	3.13
FY2023 Q3	3.56	+6.8%	—	0.29	0.17	-0.04	2.40

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →

Ticker	Company	Market Cap	P/E	Revenue YoY	Gross Margin	1M	View
UHS	Universal Health Services	$10.7B	7.0	+8.3%	—	+6.26%	Neutral
LLY	Lilly (Eli)	$1.07T	39.9	+47.7%	85.8%	−3.83%	Bullish	Compare
JNJ	Johnson & Johnson	$644B	30.6	+6.6%	68.2%	+1.87%	Bullish	Compare
ABBV	AbbVie	$464B	73.7	+10.2%	74.7%	+4.87%	Neutral	Compare
MRK	Merck & Co.	$358B	112.2	+5.1%	73.5%	+6.57%	Neutral	Compare
UNH	UnitedHealth Group	$337B	23.9	+0.4%	88.1%	−5.15%	Neutral	Compare
TMO	Thermo Fisher Scientific	$240B	34.4	+10.5%	—	+10.75%	Bullish	Compare
AMGN	Amgen	$203B	23.3	+9.5%	72.0%	−10.26%	Neutral	Compare
GILD	Gilead Sciences	$183B	—	+10.2%	79.8%	+6.31%	Neutral	Compare

The View in One Line

Revenue of only $4.64 billion, no year-over-year comparison or gross margin, stock up 6% for the month, insufficient information, Neutral.

Updated 2026-09-16

Key Events

08-21Capital Actions
UHS Issues $1.1 Billion of Senior Secured Notes
On August 20, 2026, UHS completed the issuance of $600 million of 5.500% senior secured notes due 2031 and $500 million of 6.000% senior secured notes due 2036.Source ↗
08-17M&A / Contracts
UHS Completes Acquisition of Talkspace
On August 17, 2026, UHS completed its merger with Talkspace at $5.25 per share in cash, funded through a $400 million term loan and revolving credit facility.Source ↗
08-13Capital Actions
UHS Issues $1.1 Billion Senior Secured Notes
On August 11, 2026, UHS entered into an agreement with several underwriters to issue $600 million of 5.500% senior secured notes due 2031 and $500 million of 6.000% senior secured notes due 2036.Source ↗
07-21Capital Actions
UHS Adds $700 Million Delayed Draw Term Loan
On July 20, 2026, Universal Health Services amended its credit agreement to add up to $700 million in delayed draw term loans, available for draw until September 30.Source ↗
05-22Governance
UHS Annual Shareholder Meeting Completes Director Elections and Auditor Reappointment
On May 20, 2026, UHS's shareholder meeting elected Alan B. Miller and Nina Chen-Langenmayr as directors and approved the reappointment of PricewaterhouseCoopers as auditor for fiscal 2026.Source ↗
05-21Management Change
Behavioral Health Segment President Resigns; CEO Assumes Duties Temporarily
Matthew J. Peterson resigned as Executive Vice President and President of the Behavioral Health segment on May 18, 2026, effective June 19; CEO Marc D. Miller will temporarily oversee the segment.Source ↗
04-24Capital Actions
UHS Adds $900 Million in Credit Facilities
On April 22, 2026, UHS amended its credit agreement, adding a $200 million revolving loan, a $300 million term loan and a $400 million delayed draw term loan, maturing September 2029.Source ↗
03-30Management Change
UHS Approves 2026 Executive Bonus Plan
On March 26, 2026, the UHS board's compensation committee approved the 2026 executive bonus formula and paid Executive Chairman Alan B. Miller a discretionary cash bonus of $1.07 million for 2025.Source ↗

Key Financial Trends

Quarterly Revenue ($B)4.6

Free Cash Flow ($B)0.2